recall
saveZydus Pharmaceuticals (USA) Inc recall (Cls II)
community read0 votes
Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals, Pennington, NJ 08534. NDC 68382-110-06 — Reason: Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules. — Status: Ongoing
view source ↗Data sources
last refreshed 2m ago
Found something off?
same company · ±60 days · 6
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls III)Dec 10, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls III)Dec 17, 2025
- recallLupin Pharmaceuticals Inc. recall (Cls II)Dec 17, 2025
comments(0)
5-min edit window · permanent after that